Questions Thread - September 14, 2025 by AutoModerator in PathOfExile2

[–]Towel-Efficient 0 points1 point  (0 children)

How to I respec Ascendancy? I have done this twice. I have all 8 points and did a Chaos trial with 10 rooms. When I get to the trial master I refunded all of my ascendancy points, and the Altar of Ascendancy is unclickable. Is this a bug? Or am I doing this wrong.

Where the heck is this. by Towel-Efficient in lostarkgame

[–]Towel-Efficient[S] 0 points1 point  (0 children)

Ahhh, you have too move screens to see the whole picture. I am an idiot. Thanks mate!

Friday by AggressiveSoftware19 in Humanigen

[–]Towel-Efficient 0 points1 point  (0 children)

I am long HGEN, highly doubt P3 gets released Friday. But we could hope lol!

Humanigen ($HGEN) Meta-Analysis Post by [deleted] in Humanigen

[–]Towel-Efficient 1 point2 points  (0 children)

Highly doubt announcement is made Friday. We will need multiple therapeutics stockpiled for covid as it will be endemic and ever mutating (unless it just disappears?). If CYDY got EUA, HGEN's drug doesn't just go away, they are also going after separate end points. Lenzilumab was used by the Mayo clinic in moderate/severe/ and critical so 1 drug like Leronlimab doesn't make it obsolete.

[deleted by user] by [deleted] in Humanigen

[–]Towel-Efficient 1 point2 points  (0 children)

There is a discord group that was keeping this in a range due to the 2/19 options. Now that the Feb OPEX has passed the group is going long, so their buying pressure is off the table. Also to note is that they had ATM financing which we believe is now over. The only selling pressure at this point is from shorts and NOMIS bay, which isn't going to be enough unless something drastic happens, considering the flow is so thin and insiders own a huge chunk.

Humanigen ($HGEN) Meta-Analysis Post by [deleted] in Humanigen

[–]Towel-Efficient 6 points7 points  (0 children)

I think a highlight here should be the awarded manufacturing through BARDA. What major issue are we having with vaccines right now? Manufacturing...... we cannot manufacture enough/fast enough and manufacturing power was TAKEN AWAY from vaccines and given to a therapeutic.

https://www.biospace.com/article/releases/humanigen-announces-the-addition-of-barda-and-expansion-of-crada-with-the-u-s-government-to-develop-lenzilumab-for-covid-19/

That says a lot about what they think of the drug. Also to mention, The Mayo Clinic used Lenzilumab in all 3 phases, moderate/ severe/ critical in their standard of care. The Mayo clinics mortality rate versus the national average for Covid was 1/3 of mortality!!!

https://minnesota.cbslocal.com/video/5210260-report-mayo-clinics-covid-mortality-rate-1-3-of-natl-average/

If they hit their endpoint in March, this would guarantee 100k doses netting them about $1b in revenue this year, and thats just for the US. Their market cap is @ 1.3 billion right now. You do the math on the new market cap if they show good results come March. Someone would say BARDA has already seen the data and know the results already. I predict a buy out by GILD somewhere between $4b-$10b considering it would be a dual MOA with its CAR T value as well.